Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhashree Kumaravel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Physiology. Cell Physiology|October 14, 2020
The β<sub>1</sub>-integrin plays a key role in LEC invasion in an optimized 3-D collagen matrix modelSubhashree Kumaravel, Colette A Abbey, Kayla J Bayless, et al.
Indian Journal of Surgical Oncology|May 17, 2021
Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck CancersSumeet Singh, Subhashree Kumaravel, Saurabh Dhole, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 30, 2020
Hypoxic tumor microenvironment: Implications for cancer therapySukanya Roy, Subhashree Kumaravel, Ankith Sharma, et al.
Life Sciences|February 7, 2021
Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expressionDoulathunnisa Jaffar Ali, Cong He, Huantian Xu, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2023
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustionKumaravel Mohankumar, Gus Wright, Subhashree Kumaravel, et al.
Cells|February 25, 2023
Conjugated Bile Acids Promote Lymphangiogenesis by Modulation of the Reactive Oxygen Species-p90RSK-Vascular Endothelial Growth Factor Receptor 3 PathwayPriyanka Banerjee, Subhashree Kumaravel, Sukanya Roy, et al.
Experimental Cell Research|May 8, 2020
Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenibCong He, Doulathunnisa Jaffar Ali, Huantian Xu, et al.
The American Journal of Pathology|February 9, 2020
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck CancersSubhashree Kumaravel, Sumeet Singh, Sukanya Roy, et al.
Cells|November 27, 2021
Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote CholangiocarcinomaSukanya Roy, Subhashree Kumaravel, Priyanka Banerjee, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Physiology. Cell Physiology|October 14, 2020
The β<sub>1</sub>-integrin plays a key role in LEC invasion in an optimized 3-D collagen matrix modelSubhashree Kumaravel, Colette A Abbey, Kayla J Bayless, et al.
Indian Journal of Surgical Oncology|May 17, 2021
Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck CancersSumeet Singh, Subhashree Kumaravel, Saurabh Dhole, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 30, 2020
Hypoxic tumor microenvironment: Implications for cancer therapySukanya Roy, Subhashree Kumaravel, Ankith Sharma, et al.
Life Sciences|February 7, 2021
Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expressionDoulathunnisa Jaffar Ali, Cong He, Huantian Xu, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2023
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustionKumaravel Mohankumar, Gus Wright, Subhashree Kumaravel, et al.
Cells|February 25, 2023
Conjugated Bile Acids Promote Lymphangiogenesis by Modulation of the Reactive Oxygen Species-p90RSK-Vascular Endothelial Growth Factor Receptor 3 PathwayPriyanka Banerjee, Subhashree Kumaravel, Sukanya Roy, et al.
Experimental Cell Research|May 8, 2020
Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenibCong He, Doulathunnisa Jaffar Ali, Huantian Xu, et al.
The American Journal of Pathology|February 9, 2020
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck CancersSubhashree Kumaravel, Sumeet Singh, Sukanya Roy, et al.
Cells|November 27, 2021
Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote CholangiocarcinomaSukanya Roy, Subhashree Kumaravel, Priyanka Banerjee, et al.
Pageof 1